VHCP MANAGEMENT, LLC
Latest 13F filing data - Q4 2016
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
 | BCRX | 1.16M | $7.31M |
 | ADVM | 1.10M | $3.20M |
 | HRTX | 1.10M | $14.35M |
 | LPCN | 850K | $3.13M |
 | CHRS | 306K | $8.60M |
 | AKTX | 158K | $1.11M |
 | ASND | 90K | $1.82M |
 | CTMX | 64K | $706.00K |
 | BOLD | 15K | $274.00K |
BioCryst Pharmaceuticals, Inc.
BCRX
Shares Held
1.16M
Value
$7.31M
Adverum Biotechnologies, Inc.
ADVM
Shares Held
1.10M
Value
$3.20M
Heron Therapeutics, Inc.
HRTX
Shares Held
1.10M
Value
$14.35M
Lipocine Inc.
LPCN
Shares Held
850K
Value
$3.13M
Coherus Oncology, Inc.
CHRS
Shares Held
306K
Value
$8.60M
Akari Therapeutics, Plc
AKTX
Shares Held
158K
Value
$1.11M
Ascendis Pharma A/S
ASND
Shares Held
90K
Value
$1.82M
CytomX Therapeutics, Inc.
CTMX
Shares Held
64K
Value
$706.00K
Boundless Bio, Inc.
BOLD
Shares Held
15K
Value
$274.00K